Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.

Venturutti, L; Russo, R I Cordo; Rivas, M A; Mercogliano, M F; Izzo, F; Oakley, R H; Pereyra, M G; De Martino, M; Proietti, C J; Yankilevich, P; Roa, J C; Guzmán, P; Cortese, E; Allemand, D H; Huang, T H; Charreau, E H; Cidlowski, J A; Schillaci, R; Elizalde, P V

Venturutti, L; Russo, R I Cordo; Rivas, M A; Mercogliano, M F; Izzo, F; Oakley, R H; Pereyra, M G; De Martino, M; Proietti, C J; Yankilevich, P; Roa, J C; Guzmán, P; Cortese, E; Allemand, D H; Huang, T H; Charreau, E H; Cidlowski, J A; Schillaci, R; Elizalde, P V.

Afiliação

Venturutti L; Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
Russo RIC; Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
Rivas MA; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Mercogliano MF; Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
Izzo F; Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
Oakley RH; Department of Health and Human Services, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
Pereyra MG; Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
De Martino M; Servicio de Anatomía Patológica, Hospital General de Agudos 'Juan A Fernández', Buenos Aires, Argentina.
Proietti CJ; Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
Yankilevich P; Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
Roa JC; Instituto de Investigación en Biomedicina de Buenos Aires, CONICET-Partner Institute of the Max Planck Society, Buenos Aires, Argentina.
Guzmán P; Departamento de Anatomía Patológica (BIOREN), Universidad de La Frontera, Temuco, Chile.
Cortese E; Departamento de Anatomía Patológica, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
Allemand DH; Advanced Center for Chronic Diseases (ACCDIS), Pontificia Universidad Católica de Chile, Santiago de Chile, Santiago, Chile.
Huang TH; Departamento de Anatomía Patológica (BIOREN), Universidad de La Frontera, Temuco, Chile.
Charreau EH; Servicio de Ginecología, Hospital Aeronáutico Central, Buenos Aires, Argentina.
Cidlowski JA; Unidad de Patología Mamaria, Hospital General de Agudos 'Juan A Fernández', Buenos Aires, Argentina.
Schillaci R; Department of Molecular Medicine/Institute of Biotechnology, Cancer Therapy and Research Center, University of Texas, San Antonio, TX, USA.
Elizalde PV; Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.

Oncogene ; 42(50): 3719, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37978227

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Argentina

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google